French Observatory of Acute Heart Failure (OFICA)

September 11, 2023 updated by: French Cardiology Society

During the last decade, progress has been made in the management of heart failure. However, the changing characteristics of patients and practices in the "real world" and their impact on the prognosis of patients admitted for acute heart failure remain poorly studied.

2000 consecutive patients recruited in a single day in hospitals volunteered to participate in the cohort during a day dedicated.

Study Overview

Status

Completed

Conditions

Detailed Description

The total duration of recruitment is one day (date to be set soon by the Executive Committee): all patients hospitalized, and whatever their date of admission with the diagnosis of heart failure will be selected for the study.

Information on each hospital stay will be obtained at baseline and at the end of the hospitalization by the hospital teams.

A telephone follow-up will be conducted at 3 months among survivors and / or their doctor by CRAs dedicated to the French Society of Cardiology.

Study Type

Observational

Enrollment (Actual)

1818

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75010
        • Lariboisiere Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Hospitalized patient, whatever the mode of initial admission with acute heart failure (de novo heart failure or decompensation of chronic heart failure)

Description

Inclusion Criteria:

  1. Male or female age (e) over 18 years
  2. Inpatient, whatever the mode of initial admission with acute heart failure (de novo heart failure or decompensation of chronic heart failure) regardless of severity, corresponding to one of the following clinical situations (clinical criteria in Appendix 1):

    • Pulmonary edema, hypertensive or not
    • congestive heart failure (pulmonary congestion and peripheral edema)
    • cardiogenic shock
    • Insufficient high output cardiac
  3. Patients who agreed to participate in the study
  4. Isolated right heart failure

Exclusion Criteria:

  1. expressed refusal to participate in the study
  2. Hospitalization scheduled for review
  3. Background surgery (immediate postoperative period)
  4. Diagnosis of acute heart failure reversed in favor of an alternative diagnosis before discharge from hospital

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patient with acute heart failure
Hospitalized patient, whatever the mode of initial admission with acute heart failure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival at 3 months
Time Frame: 3 months
Analyze survival 3 months after the end of initial hospitalization
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital Methods
Time Frame: 3 months
Compare methods of care based on clinical characteristics and hospital structures.
3 months
Patterns of admission
Time Frame: 3 months
Analyze patterns of admission and discharge of patients, depending on their characteristics
3 months
Co-morbidities
Time Frame: 3 months
Analyze the co-morbidities and their impact on care and survival
3 months
Drug treatments
Time Frame: 3 months
Analyze the evolution of drug treatment between the output and monitoring to 3 months
3 months
Resources specific diagnostic
Time Frame: 3 months
Analyze the use of resources specific diagnostic: measurement of BNP or NTproBNP, conducting echocardiogram, coronary angiography, Holter-ECG, Cardiac MRI, Cardiac CT
3 months
Therapeutic resources
Time Frame: 3 months
Analyze the use of therapeutic resources based on specific clinical features: intensive care, ventilation, inotropes, ultrafiltration, introduction of beta-blockers, stimulation, implantable cardioverter defibrillator, circulatory support, graft
3 months
During of stay
Time Frame: 3 months
Analyze the duration of stay according to clinical characteristics.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Damien DL LOGEART, French Cardiology Society

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2009

Primary Completion (Actual)

December 1, 2010

Study Completion (Actual)

February 1, 2011

Study Registration Dates

First Submitted

March 1, 2010

First Submitted That Met QC Criteria

March 4, 2010

First Posted (Estimated)

March 5, 2010

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 11, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SFC-OFICA

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Heart Failure

Subscribe